JP2008540628A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540628A5
JP2008540628A5 JP2008511798A JP2008511798A JP2008540628A5 JP 2008540628 A5 JP2008540628 A5 JP 2008540628A5 JP 2008511798 A JP2008511798 A JP 2008511798A JP 2008511798 A JP2008511798 A JP 2008511798A JP 2008540628 A5 JP2008540628 A5 JP 2008540628A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
hydroxyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008511798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540628A (ja
JP5227166B2 (ja
Filing date
Publication date
Priority claimed from GB0510345A external-priority patent/GB2426247A/en
Application filed filed Critical
Publication of JP2008540628A publication Critical patent/JP2008540628A/ja
Publication of JP2008540628A5 publication Critical patent/JP2008540628A5/ja
Application granted granted Critical
Publication of JP5227166B2 publication Critical patent/JP5227166B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008511798A 2005-05-20 2006-05-19 ファムシクロビルおよび他のプリン誘導体の調製 Expired - Fee Related JP5227166B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0510345A GB2426247A (en) 2005-05-20 2005-05-20 Methods of preparing purine derivatives such as famciclovir
GB0510345.2 2005-05-20
PCT/GB2006/001877 WO2006123175A1 (en) 2005-05-20 2006-05-19 Preparation of famciclovir and other purine derivatives

Publications (3)

Publication Number Publication Date
JP2008540628A JP2008540628A (ja) 2008-11-20
JP2008540628A5 true JP2008540628A5 (enExample) 2009-04-30
JP5227166B2 JP5227166B2 (ja) 2013-07-03

Family

ID=34834391

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511798A Expired - Fee Related JP5227166B2 (ja) 2005-05-20 2006-05-19 ファムシクロビルおよび他のプリン誘導体の調製

Country Status (17)

Country Link
US (1) US7601835B2 (enExample)
EP (1) EP1883639B1 (enExample)
JP (1) JP5227166B2 (enExample)
CN (1) CN101233134B (enExample)
AT (1) ATE479688T1 (enExample)
AU (1) AU2006248745B2 (enExample)
BR (1) BRPI0609632A2 (enExample)
CA (1) CA2608490C (enExample)
DE (1) DE602006016593D1 (enExample)
DK (1) DK1883639T3 (enExample)
ES (1) ES2351925T3 (enExample)
GB (1) GB2426247A (enExample)
NZ (1) NZ563636A (enExample)
PL (1) PL1883639T3 (enExample)
PT (1) PT1883639E (enExample)
TW (1) TW200716638A (enExample)
WO (1) WO2006123175A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040097528A1 (en) * 2002-08-26 2004-05-20 Ben-Zion Dolitzky Crystalline solid famciclovir forms I, II, III and preparation thereof
WO2004099208A1 (en) * 2003-04-30 2004-11-18 Teva Pharmaceutical Industries Ltd. Process for the preparation of famciclovir
KR20080091298A (ko) * 2004-05-18 2008-10-09 테바 파마슈티컬 인더스트리즈 리미티드 결정성 고체 팜시클로버의 제조를 위한 건조방법
WO2008072074A1 (en) * 2006-12-11 2008-06-19 Aurobindo Pharma Limited An improved process for the preparation of purine derivative
CN101555249B (zh) * 2008-04-08 2011-05-11 浙江海正药业股份有限公司 泛昔洛韦的合成方法
CN102924455A (zh) * 2011-08-11 2013-02-13 重庆圣华曦药业股份有限公司 一种泛昔洛韦中间体的合成方法
CN104496991A (zh) * 2014-11-04 2015-04-08 常州康丽制药有限公司 高品质2-氨基-6-氯-9-(4-羟基-3–羟甲基丁基)嘌呤的制备方法
CN104744472A (zh) * 2015-03-12 2015-07-01 常州康丽制药有限公司 高品质2-氨基-6-氯-9-(4-羟基-3-羟甲基丁基)嘌呤的制备方法
CN109456329B (zh) * 2018-11-19 2021-03-09 迪嘉药业集团有限公司 一种泛昔洛韦的制备方法
CN114787129B (zh) 2019-12-11 2025-07-04 塔罗制药工业有限公司 曲法罗汀及其中间体和多晶型物的制备
CN112979653A (zh) * 2019-12-12 2021-06-18 上药康丽(常州)药业有限公司 一种利用微通道反应器合成泛昔洛韦的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
GB8817607D0 (en) * 1988-07-23 1988-09-01 Beecham Group Plc Novel process
GB8822236D0 (en) 1988-09-21 1988-10-26 Beecham Group Plc Chemical process
GB9402161D0 (en) 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
GB9407698D0 (en) * 1994-04-19 1994-06-15 Smithkline Beecham Plc Pharmaceuticals
JPH11180983A (ja) 1997-12-24 1999-07-06 Sumika Fine Chemicals Co Ltd 9置換2−アミノ−6−ハロゲノプリンおよびその製法
GB9807116D0 (en) * 1998-04-02 1998-06-03 Smithkline Beecham Plc Novel process
GB9807114D0 (en) * 1998-04-02 1998-06-03 Smithkline Beecham Plc Novel process
SI20022A (sl) * 1998-07-29 2000-02-29 Kemijski inštitut Alkilno substituirani purinovi derivati in njihova priprava
DE60202245T2 (de) 2001-08-30 2005-09-01 Ajinomoto Co., Inc. Herstellungsmethode von Famciclovir und Herstellungs- bzw. Kristallisationsmethode eines entsprechenden Intermediates
JP2003146988A (ja) * 2001-08-30 2003-05-21 Ajinomoto Co Inc ファムシクロビルの製造方法、並びにその中間体の製造および晶析方法
KR100573860B1 (ko) 2003-06-13 2006-04-25 경동제약 주식회사 2-아미노-9-(2-치환에틸)푸린을 이용한 9-[4-아세톡시-3-(아세톡시메틸)부트-1-일]-2-아미노푸린의 제조방법
US20050215787A1 (en) * 2004-03-26 2005-09-29 Joshi Ramesh A An improved process for the preparation of purines

Similar Documents

Publication Publication Date Title
JP2010532340A5 (enExample)
ES2746801T3 (es) Proceso de preparación de agonistas beta-3 y productos intermedios
JP2008540628A5 (enExample)
IL175024A0 (en) Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters
CA2657483A1 (en) Macrolide synthesis process
WO2007031548A3 (en) Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
JP2009298770A5 (enExample)
JP2010532365A5 (enExample)
JP2010529994A5 (enExample)
RU2012122367A (ru) Способ получения простагландинов и промежуточные соединения для их получения
JP2008286881A5 (enExample)
JP2018502174A5 (enExample)
JP2013521224A5 (enExample)
Das et al. Stereoselective direct reductive amination of ketones with electron-deficient amines using Re 2 O 7/NaPF 6 catalyst
JP2011502147A5 (enExample)
WO2007049295B1 (en) An improved one pot process for making key intermediate for gemcitabine hcl
JP2007045816A5 (ja) カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法
WO2008053496A4 (en) An improved process for the manufacture of cis (-)-lamivudine
JP6228210B2 (ja) フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法
WO2020183295A1 (en) Process for preparation of tofacitinib and pharmaceutically acceptable salt thereof
JP2007210969A5 (enExample)
BRPI0616169B8 (pt) cloridrato de lercanidipina na forma polimorfa v, composição farmacêutica compreendendo dito composto e processos para preparação de cloridrato de lercanidipina
EP2917192A2 (en) Process for the preparation of cabazitaxel and its intermediates
JP2011503175A5 (enExample)
JP2004503519A5 (enExample)